Sponsor or institution
Clinical trials and research at Centre de recherche du Centre hospitalier universitaire de Sherbrooke
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Centre de recherche du Centre hospitalier universitaire de Sherbrooke that are recruiting, in Canada. By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Thyroid artery embolization to relieve compressive goiters. | — | Sherbrooke, Quebec | Recruiting | Jan 22, 2026 |
| Imaging HER2-low breast cancers using a specialized PET scan | Phase 1/2 | Sherbrooke, Quebec | Recruiting | Dec 13, 2024 |
| Using 68Ga-PSMA-617 PET imaging for solid cancers | — | Sherbrooke, Quebec | Recruiting | Feb 8, 2022 |
| Imaging Estrogen Receptor Positive Advanced Breast Cancers | Phase 2 | Sherbrooke, Quebec | Recruiting | Apr 1, 2021 |
| Imaging neuroblastoma using 68Ga-DOTATATE | Phase 2 | Montreal, Quebec and 2 other locations | Recruiting | Sep 22, 2020 |
All recruiting trials (5)
-
Thyroid artery embolization to relieve compressive goiters.
This will see if blocking blood flow to the thyroid (thyroid artery embolization) can safely shrink nodular goiters and relieve breathing or swallowing problems in adults who are ineligible for or decline surgery.
-
Imaging HER2-low breast cancers using a specialized PET scan
This study is testing a new type of PET scan that uses a special version of a breast cancer drug to see if it can better find HER2-low breast cancers that might have been missed before.
-
Using 68Ga-PSMA-617 PET imaging for solid cancers
This study is testing a new type of imaging called 68Ga-PSMA-617 to see if it can help doctors better detect and manage solid tumors that express PSMA, not just prostate cancer.
-
Imaging Estrogen Receptor Positive Advanced Breast Cancers
This study is testing a new type of PET imaging to see if it can help doctors better understand estrogen receptor levels in patients with advanced breast cancer, which may improve their treatment options.
-
Imaging neuroblastoma using 68Ga-DOTATATE
This study is testing a new type of imaging called 68Ga-DOTATATE PET/CT to see if it works better and is safer than the standard method for detecting neuroblastoma in both children and adults.
Quick answers
How many clinical trials run by Centre de recherche du Centre hospitalier universitaire de Sherbrooke are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Canada. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.